Iqvia Holdings (IQV) Current Deferred Revenue (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Current Deferred Revenue came in at $2.3 billion in Q1 2026, up 16.55% year-on-year from $1.9 billion in Q1 2025, and up 6.75% quarter-over-quarter from $2.1 billion in Q4 2025.
Iqvia Holdings (IQV) Current Deferred Revenue (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Current Deferred Revenue across 15 years of filings, most recently posting $2.3 billion for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $2.3 billion, up 16.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 16.55% YoY), and the FY2025 annual result was $2.1 billion, up 19.06% from the prior year.
- Current Deferred Revenue came in at $2.3 billion for Q1 2026 at Iqvia Holdings, up from $2.1 billion in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $2.3 billion in Q1 2026 to a low of $1.8 billion in Q4 2024.
- The 5-year median for Current Deferred Revenue is $1.8 billion (2022), against an average of $1.9 billion.
- Across the five-year window, Current Deferred Revenue advanced 24.0% in 2022 and declined 5.19% in 2023, its largest moves.
- Iqvia Holdings' Current Deferred Revenue stood at $1.8 billion in 2022, then rose by 0.11% to $1.8 billion in 2023, then dropped by 1.11% to $1.8 billion in 2024, then grew by 19.06% to $2.1 billion in 2025, then increased by 6.75% to $2.3 billion in 2026.
- The last three Current Deferred Revenue figures came in at $2.3 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Bn |
| Dec 31, 2025 | 2.12 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.12 Bn |
| Mar 31, 2025 | 1.94 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.82 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.84 Bn |
| Jun 30, 2023 | 1.84 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.93 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.83 Bn |
| Jun 30, 2021 | 1.60 Bn |